Brief: Lineage Reports First Quarter 2021 Financial Results And Highlights Significant Progress With All Three Clinical Programs
13/05/2021 22:35
May 13 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND
HIGHLIGHTS SIGNIFICANT PROGRESS WITH ALL THREE CLINICAL PROGRAMS
* LINEAGE CELL THERAPEUTICS INC- QTRLY LOSS PER SHARE $0.01
Source text for Eikon: ID:nBw3PBtmka
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million